Effects of Aromatherapy with Essential Oils on Anxiety and Depression in Perioperative Patients with Pancreatic Cancer

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPeking University First Hospital

About this trial

The objective of this study is to investigate whether aromatherapy essential oils are effective in alleviating anxiety and depression in participants undergoing perioperative pancreatic cancer treatment. Researchers compared aromatherapy essential oils with a placebo (a substance that appears similar but contains no essential oils) to determine their efficacy in reducing anxiety and depression in these participants. Participants were required to undergo aromatherapy for 2 hours daily over a period of 15 days. Assessments of anxiety and depression were conducted one day before surgery, 14 days after surgery, and 42 days after surgery, with their scores recorded accordingly.

Eligibility criteria

Qualifiers

Meet diagnostic criteria in Chinese Anti-Cancer Association Guidelines for pancreatic cancer

Age ≥18 years

Contraception required, non-lactation period

Consistent with surgical indications

Disqualifiers

History of mental illness or cognitive impairment

Severe liver/kidney disease, cardiopulmonary dysfunction, tumor recurrence/metastasis

Allergy or intolerance to aromatic reagents, olfactory disorders, acute respiratory disease, serious complications (unstable vital signs, blood clotting disorders, irreversible metabolic diseases)

Poor compliance with study protocol or participation in similar studies

Trial design

Treatments tested in this trial

  • Experimental: Aromatherapy with essential oil intervention
  • Control Group 0.9% Isotonic Saline

Treatment groups

156 Participants
are divided into 2 treatment groups

Locations

This trial has no locations